Skip to main content
PLPCPreformed Line Products CompanySell4.4·$384.31+0.22%
PLPC · Why this verdict

Why Preformed Line Products (PLPC) is rated SELL

Updated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

VerdictSELL
Overall score4.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis

Engine thesis — one sentence

Preformed Line Products is a small industrial components maker that has beaten earnings in 3 of 4 recent quarters but faces severely negative asymmetry with the stock trading above analyst targets, earnings estimates collapsing 47.7% in the last 30 days, and an overall score of only 4.1 out of 10.

Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.

Thesis pillars

Forward earnings estimates for Preformed Line Products have declined 47.7% in the last 30 days — the sharpest estimate revision seen in this batch — suggesting analysts have materially revised their outlook for the company's profitability ahead of results due in approximately 43 days.

Stable
Catalyst breakdown
Expectation
Earnings estimates stabilize or recover above current levels within 2 quarters, suggesting the negative revision has fully captured the fundamental risk.

CounterA 47.7% forward estimate decline may be accurate and reflect a genuine structural change in the company's pricing power or input cost structure that will persist for multiple quarters.

Despite deteriorating forward estimates, Preformed Line Products has beaten consensus estimates in 3 of the last 4 quarters with an average surprise of 4.8%, including a 17.6% beat in the most recent April 2026 quarter, suggesting management execution remains intact.

Stable
Earnings
Expectation
The company beats earnings estimates in the next quarterly report due in approximately 43 days with at least a 5% positive surprise.

CounterA 3-out-of-4 beat record with only a 4.8% average surprise is modest, and the most recent beat may have been the last easy one given the steep estimate revision of -47.7% over the last 30 days.

Preformed Line Products has an implied upside of -16.8% from its current price of $380.16 to the analyst target — meaning the stock is trading well above consensus fair value estimates — and the risk/reward ratio of 0.34 does not justify adding risk at current levels.

Stable
Warnings
Expectation
Analyst price targets are revised upward above $400 within 12 months if quarterly results exceed the recently reduced estimates.

CounterStocks can trade above analyst price targets for extended periods if the market anticipates continued earnings beats or strategic events that analysts have not yet incorporated into their models.

Free cash flow represents only 42% of net income — flagged as a red flag — suggesting that a significant portion of reported earnings are accrual-based rather than cash-backed, which raises questions about the quality of the reported earnings beat history.

Stable
Quality breakdown
Expectation
Free cash flow conversion improves above 60% of net income within 12 months, validating the reported earnings quality.

CounterFCF below net income is common in capital-intensive industrials during expansion phases, and the company's strong current ratio of 10.0 suggests balance sheet liquidity is not at risk.

Per-dimension breakdown

Value

3.6/10data confidence 60%
ComponentSub-score
P/E2.2
P/S8.5
EV/EBITDA0.0

Quality

4.7/10data confidence 100%
ComponentSub-score
ROE2.5
ROA3.7
Gross margin2.2
Op margin3.1
Net margin2.5
Current ratio10.0
FCF quality3.4
Moat6.4
Piotroski F8.9
  • Earnings quality RED FLAG: 42% FCF/NI
  • Strong Piotroski F-Score: 8/9

Growth

3.8/10data confidence 67%
ComponentSub-score
Rev growth7.2
EPS growth0.4

Momentum

6.6/10data confidence 100%
ComponentSub-score
RSI5.5
MACD6.9
OBV10.0
MA position9.0
Volume1.6
  • Volume accumulation (rising OBV)
  • Above 200-day MA

Sentiment

3.5/10data confidence 100%
ComponentSub-score
Analyst rating5.0
Price target4.5
erm sentiment0.0
  • Estimates falling as sentiment proxy (-47.7%)

Insider

5.0/10data confidence 50%
ComponentSub-score
materiality5.0
holder change5.0
  • No net insider activity — $0 (0.000% of mkt cap)

Peer rank

3.1/10data confidence 80%
ComponentSub-score
value rank5.6
quality rank3.1
growth rank3.9

Technical

5.2/10data confidence 100%
ComponentSub-score
bollinger3.0
support resistance3.4
52w position9.1

Risk (lower is worse)

6.1/10data confidence 100%
ComponentSub-score
short interest4.4
days to cover8.7
volatility0.0
beta7.6
debt equity9.6

Catalyst

4.9/10data confidence 100%
ComponentSub-score
erm2.5
earnings history6.7
earnings timing5.0
surprise avg4.9
dividend safety5.2
  • Estimates down -47.7% (30d)
  • Strong earnings: 3B/1M
  • Dividend: 22.0%

How the verdict was assembled

Engine trigger

Multiple concerning factors. Consider reducing position.

Engine technical detail
verdict_path: L4:PATH_F_SELL
Passed (7)
  • MOMENTUM:6.6>=5.5
  • INSIDER:OK
  • 8K:CLEAN
  • NEWS_EVENTS:NONE_RECENT
  • EARNINGS_PROXIMITY:35d clear
  • SEMI_CYCLE_PEAK:CLEAR
  • MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
  • ASYMMETRY:-1.6=NEGATIVE
Warning (0)

none

Reward-to-Risk
-1.57
Upside
-17.7%
Downside
11.3%
Sizing output
AVOID

SetupBREAKOUT Golden cross, above all MAs, RSI 52, MACD bullish

EdgeNO_EDGE No clear edge identified

SuitabilityAGGRESSIVE MCap $1.9B<$5B

Investment implication

The F-path SELL output reflects an overall score of 4.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Momentum at 6.6) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.6=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.57 — supplementary context, not the trigger for this path.

The strongest dimensions are Momentum at 6.6, Risk (lower is worse) at 6.1, and Technical at 5.2; the weakest are Peer rank at 3.1, Sentiment at 3.5, and Value at 3.6. The V9 engine flagged 1 failed gate, producing an asymmetric reward-to-risk of -1.57 and an engine sizing output of AVOID.

What would invalidate the thesis

Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.

  • P1Forward earnings estimates for Preformed Line Products have declined 47.7% in the last 30 days — the sharpest estimate revision seen in this batch — suggesting analysts have materially revised their outlook for the company's profitability ahead of results due in approximately 43 days.

    Trip ifEarnings estimates decline by more than 20% further from current levels over the next 3 months.

  • P2Despite deteriorating forward estimates, Preformed Line Products has beaten consensus estimates in 3 of the last 4 quarters with an average surprise of 4.8%, including a 17.6% beat in the most recent April 2026 quarter, suggesting management execution remains intact.

    Trip ifEarnings miss consensus estimates by more than 10% in the next quarterly report due in approximately 43 days.

  • P3Preformed Line Products has an implied upside of -16.8% from its current price of $380.16 to the analyst target — meaning the stock is trading well above consensus fair value estimates — and the risk/reward ratio of 0.34 does not justify adding risk at current levels.

    Trip ifStock price rises above $420 while analyst price targets remain below $390, further widening the overvaluation gap by more than 10%.

  • P4Free cash flow represents only 42% of net income — flagged as a red flag — suggesting that a significant portion of reported earnings are accrual-based rather than cash-backed, which raises questions about the quality of the reported earnings beat history.

    Trip ifFree cash flow conversion falls below 20% of net income for 2 consecutive quarters.

Engine reasoning is mechanically derived from pipeline gate outputs. See decision view.

Home Stocks PLPC Why this verdict